On January 24, 2023, Arcutis Biotherapeutics Inc. (NASDAQ: ARQT) opened at $16.32, lower -1.72% from the last session. During the day, the shares moved up to $16.6328 and dropped to $16.02 before settling in for the closing price of $16.32. Price fluctuations for ARQT have ranged from $12.81 to $27.40 over the past 52 weeks.
Top 5 Undervalued Stocks To Own In 2023
Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.
Click here to download your Free Research Report…
Sponsored
Company’s average yearly earnings per share was noted -9.80% at the time writing. With a float of $58.93 million, this company’s outstanding shares have now reached $60.93 million.
The firm has a total of 147 workers. Let’s measure their productivity.
Arcutis Biotherapeutics Inc. (ARQT) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Arcutis Biotherapeutics Inc. is 1.40%, while institutional ownership is 98.40%. The most recent insider transaction that took place on Jan 17, was worth 116,655. In this transaction Director of this company sold 8,500 shares at a rate of $13.72, taking the stock ownership to the 165,825 shares. Before that another transaction happened on Jan 03, when Company’s insider sold 1,475 for $15.01, making the entire transaction worth $22,136. This insider now owns 41,564 shares in total.
Arcutis Biotherapeutics Inc. (ARQT) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 6/29/2022, the company posted -$1.31 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$1.43) by $0.12. This company achieved a return on equity of -72.62. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -9.80% per share during the next fiscal year.
Arcutis Biotherapeutics Inc. (NASDAQ: ARQT) Trading Performance Indicators
Check out the current performance indicators for Arcutis Biotherapeutics Inc. (ARQT). In the past quarter, the stock posted a quick ratio of 13.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1336.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.89, a number that is poised to hit -1.39 in the next quarter and is forecasted to reach -4.62 in one year’s time.
Technical Analysis of Arcutis Biotherapeutics Inc. (ARQT)
Analysing the last 5-days average volume posted by the [Arcutis Biotherapeutics Inc., ARQT], we can find that recorded value of 0.92 million was better than the volume posted last year of 0.9 million. As of the previous 9 days, the stock’s Stochastic %D was 87.91%. Additionally, its Average True Range was 0.92.
During the past 100 days, Arcutis Biotherapeutics Inc.’s (ARQT) raw stochastic average was set at 22.14%, which indicates a significant decrease from 79.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.41% in the past 14 days, which was higher than the 47.22% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $16.25, while its 200-day Moving Average is $19.81. Now, the first resistance to watch is $16.44. This is followed by the second major resistance level at $16.84. The third major resistance level sits at $17.05. If the price goes on to break the first support level at $15.83, it is likely to go to the next support level at $15.62. Should the price break the second support level, the third support level stands at $15.22.
Arcutis Biotherapeutics Inc. (NASDAQ: ARQT) Key Stats
There are currently 60,928K shares outstanding in the company with a market cap of 935.77 million. Presently, the company’s annual sales total 0 K according to its annual income of -206,360 K. Last quarter, the company’s sales amounted to 730 K and its income totaled -107,710 K.